OM
LJPC

Opaleye Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Opaleye Management’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-60,000
Closed -$386K – 63
2019
Q1 		$386K Buy
+60,000
New +$391K 0.11% 52
2016
Q1 		– Sell
-140,000
Closed -$3.78M – 66
2015
Q4 		$3.78M Buy
+140,000
New +$3.82M 1.58% 28

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Opaleye Management's LJPC Position: Q2 2019 in Review

Opaleye Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2019, closing a stake of 60,000 shares — an estimated $386K sold.

Opaleye Management first reported a position in LJPC in Q4 2015 and held it in 2 quarters. The position peaked at $3.78M in Q4 2015. 80 funds tracked by Wall St. Rank hold LJPC as of Q2 2019.

  • Opaleye Management reported no remaining La Jolla Pharmaceutical Company position as of Q2 2019 after selling out during the quarter.
  • Opaleye Management sold 60,000 La Jolla Pharmaceutical Company shares in Q2 2019, an estimated $386K.
  • Opaleye Management first reported a position in La Jolla Pharmaceutical Company in Q4 2015 and held it in 2 quarters.
  • Opaleye Management's La Jolla Pharmaceutical Company position peaked at $3.78M in Q4 2015.
  • 80 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2019.

Based on Opaleye Management's 13F filing for Q2 2019, filed 14 Aug 2019.